OTCPK:RMSL

Stock Analysis Report

Executive Summary

REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • REMSleep Holdings has significant price volatility in the past 3 months.
  • REMSleep Holdings is not covered by any analysts.

Share Price & News

How has REMSleep Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

14.9%

OTCPK:RMSL

-1.6%

US Medical Equipment

-1.6%

US Market


1 Year Return

-89.4%

OTCPK:RMSL

10.2%

US Medical Equipment

-3.0%

US Market

RMSL underperformed the Medical Equipment industry which returned 10.2% over the past year.

RMSL underperformed the Market in United States of America which returned -3% over the past year.


Share holder returns

RMSLIndustryMarket
7 Day14.9%-1.6%-1.6%
30 Day-30.8%-2.6%-5.7%
90 Day-72.0%7.4%0.2%
1 Year-89.4%-89.4%11.1%10.2%-0.8%-3.0%
3 Year-99.2%-99.2%65.1%60.0%38.1%29.1%
5 Yearn/a127.0%101.0%50.8%34.1%

Price Volatility Vs. Market

How volatile is REMSleep Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is REMSleep Holdings undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether REMSleep Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as REMSleep Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of RMSL’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through REMSleep Holdings regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is REMSleep Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as REMSleep Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of RMSL’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access REMSleep Holdings's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has REMSleep Holdings performed over the past 5 years?

-64.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

REMSleep Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare REMSleep Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare REMSleep Holdings's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if REMSleep Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if REMSleep Holdings has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if REMSleep Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is REMSleep Holdings's financial position?


Financial Position Analysis

REMSleep Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

REMSleep Holdings has no long term commitments.


Debt to Equity History and Analysis

REMSleep Holdings has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if REMSleep Holdings's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

REMSleep Holdings has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

REMSleep Holdings has less than a year of cash runway based on current free cash flow.

REMSleep Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 29.5% each year.


Next Steps

Dividend

What is REMSleep Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate REMSleep Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate REMSleep Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as REMSleep Holdings has not reported any payouts.

Unable to verify if REMSleep Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as REMSleep Holdings has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of REMSleep Holdings's salary, the management and board of directors tenure and is there insider trading?

US$39k

CEO Compensation


CEO

Tom Wood (73yo)

4.6yrs

Tenure

US$38,850

Compensation

Mr. Tom Wood founded the REMSleep Holdings, Inc. and has been its Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and Director since January 1, 2015. Mr. Wood served as a Vice Pr ...


CEO Compensation Analysis

Tom's remuneration is lower than average for companies of similar size in United States of America.

Tom's compensation has increased whilst company is loss making.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Tom Wood (73yo)

    Founder

    • Tenure: 4.6yrs
    • Compensation: US$38.85k
  • Jon Lane (59yo)

    Chief Technology Officer

    • Tenure: 0.0yrs
  • Russell Bird (70yo)

    Founder & Chairman of the Board

    • Tenure: 4.6yrs

Board Members

  • Elizabeth Reid

    Member of Advisory Board

    • Tenure: 0.0yrs
  • Tom Wood (73yo)

    Founder

    • Tenure: 4.6yrs
    • Compensation: US$38.85k
  • Russell Bird (70yo)

    Founder & Chairman of the Board

    • Tenure: 4.6yrs

Company Information

REMSleep Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: REMSleep Holdings, Inc.
  • Ticker: RMSL
  • Exchange: OTCPK
  • Founded: 2007
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$1.710m
  • Shares outstanding: 67.34m
  • Website: https://www.remsleeptech.com

Number of Employees


Location

  • REMSleep Holdings, Inc.
  • 637 North Orange Avenue
  • Suite 609
  • Orlando
  • Florida
  • 32789
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RMSLOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJun 2010

Biography

REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. It offers DeltaWave CPAP interface device to treat patients with sleep apne ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/25 00:25
End of Day Share Price2019/08/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.